Dynocardia, Inc.
Medical device company · Newton Center, Massachusetts, United States
Dynocardia, Inc. is a medical device company headquartered in Newton Center, Massachusetts, United States. Its earliest recorded incorporation is in 2018. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $5.1 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $4.8 million sold in a notice filed in 2025.
Dynocardia at a glance
What does Dynocardia do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $5.1 million in total (2021 to 2024). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
12 Form D notices; the most recent reported $4.8 million sold (2025).
Frequently asked questions about Dynocardia
Where is Dynocardia headquartered?
Dynocardia, Inc. is headquartered in Newton Center, Massachusetts, United States.
What does Dynocardia do?
Dynocardia, Inc. is a medical device company.
When was Dynocardia founded?
The earliest incorporation on record for Dynocardia, Inc. is in 2018, according to public company registers.
Similar companies
- GLAUKOS CorpAliso Viejo, California, United States
- Mobia Medical, Inc.Austin, Texas, United States
- Pulse Biosciences, Inc.Hayward, California, United States
- Artivion, Inc.Kennesaw, Georgia, United States
- PAVmed Inc.New York City, New York, United States
- Medtronic IncMinneapolis, Minnesota, United States
- Sintx Technologies, Inc.Salt Lake City, Utah, United States
- Axogen, Inc.Alachua, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.